Earnings
LUMO
10.80
-1.10%
-0.12
Currencies: USD
Items
Total Revenue
Revenue
Cost of Revenue
Gross Profit
Marketing and Administrative Expenses
Research and Development Costs
Financial Expenses
Depreciation and Amortization
Other Expenses
Total Operating Expenses
Asset Impairments
Operating Income
Interest Income
Assets Disposal
Other Non-operating Net Income
Non-operating Income
Net Income Before Taxes
Provision for Income Taxes
Net Income
Minority Interests
Net Income Attributable to Shareholders
Net Income Attributable to Common Equities
Net Income from Discontinued Operations
Basic EPS
Diluted EPS
FY 2020-12-31
168.00K
168.00K
--
--
17.27M
9.21M
--
--
--
26.47M
--
-26.30M
200.00K
--
6.47M
--
-19.64M
-13.97M
-5.66M
--
-5.66M
-6.31M
--
--
-0.93
FY 2019-12-31
936.00K
936.00K
--
--
20.57M
19.91M
--
--
--
46.07M
--
-45.13M
2.18M
--
-19.00K
--
-42.98M
12.00K
-42.99M
--
-42.99M
-42.99M
--
--
-10.37
FY 2018-12-31
12.47M
12.47M
--
--
28.42M
45.19M
--
--
--
74.91M
--
-62.44M
1.98M
--
-102.00K
--
-60.56M
-6.97M
-53.59M
--
-53.59M
-53.59M
--
--
-12.97
FY 2017-12-31
28.71M
28.71M
--
--
30.63M
69.27M
--
--
--
101.59M
--
-72.88M
497.00K
--
-126.00K
--
-72.51M
-559.00K
-71.95M
--
-71.95M
-71.95M
140.00K
--
-20.69
FY 2016-12-31
35.77M
35.77M
--
--
32.73M
82.20M
--
--
--
126.53M
--
-90.76M
215.00K
--
32.00K
--
-90.51M
-5.36M
-85.16M
--
-85.16M
-85.16M
--
--
-26.45

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out LUMO latest quarterly and annual financial reports. There are also past financial reports for you to reference. You can analyze Lumos Pharma recent business situations from balance sheets, income statements, cash flow statements and other tables. This information may help you make smarter investment decisions.